Caprock Group LLC purchased a new stake in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 3,029 shares of the semiconductor company's stock, valued at approximately $376,000.
Other large investors have also modified their holdings of the company. Wellington Management Group LLP increased its holdings in shares of Silicon Laboratories by 28.3% in the 3rd quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company's stock valued at $102,670,000 after acquiring an additional 195,997 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Silicon Laboratories during the third quarter worth $7,408,000. FMR LLC boosted its position in Silicon Laboratories by 1.1% during the third quarter. FMR LLC now owns 4,843,370 shares of the semiconductor company's stock worth $559,748,000 after purchasing an additional 54,708 shares in the last quarter. Schwartz Investment Counsel Inc. raised its holdings in shares of Silicon Laboratories by 17.9% in the third quarter. Schwartz Investment Counsel Inc. now owns 230,000 shares of the semiconductor company's stock worth $26,581,000 after acquiring an additional 35,000 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in Silicon Laboratories by 1,106.4% in the fourth quarter. SG Americas Securities LLC now owns 23,791 shares of the semiconductor company's stock valued at $2,955,000 after purchasing an additional 21,819 shares during the last quarter.
Insider Buying and Selling at Silicon Laboratories
In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the business's stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the sale, the director now directly owns 32,115 shares of the company's stock, valued at $4,520,828.55. The trade was a 5.86 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Navdeep S. Sooch sold 2,360 shares of the business's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the transaction, the director now owns 400,567 shares in the company, valued at $59,684,483. This represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.72% of the company's stock.
Analyst Ratings Changes
A number of analysts have weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of Silicon Laboratories from $150.00 to $135.00 and set an "overweight" rating on the stock in a research report on Tuesday, November 5th. StockNews.com upgraded Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Thursday. KeyCorp boosted their price target on Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 22nd. Needham & Company LLC upped their target price on Silicon Laboratories from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Wednesday. Finally, Benchmark upgraded Silicon Laboratories from a "hold" rating to a "buy" rating and set a $160.00 price target on the stock in a research report on Wednesday. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Silicon Laboratories currently has an average rating of "Moderate Buy" and a consensus target price of $136.20.
Read Our Latest Stock Analysis on SLAB
Silicon Laboratories Stock Performance
Shares of NASDAQ SLAB traded down $4.74 during mid-day trading on Friday, reaching $142.66. The company had a trading volume of 418,568 shares, compared to its average volume of 374,538. The company has a market capitalization of $4.63 billion, a price-to-earnings ratio of -24.02 and a beta of 1.16. Silicon Laboratories Inc. has a 12-month low of $94.00 and a 12-month high of $154.91. The stock has a fifty day moving average of $129.76 and a two-hundred day moving average of $117.14.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11). The business had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm's revenue for the quarter was up 91.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($1.19) EPS. Sell-side analysts forecast that Silicon Laboratories Inc. will post -0.47 earnings per share for the current fiscal year.
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Stories

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report